Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial - Reuters

Reuters | Jan. 8, 2026, 2:16 p.m. | Original
Lilly’s Zepbound plus Taltz boosts arthritis relief, weight loss in late-stage trial Reuters
Italy’s privacy watchdog warns Grok over deepfake AI content - Reuters CrowdStrike to buy identity security startup SGNL for $740 million to tackle AI threats - Reuters